Skip to content

The effects of Nutrition monitoring app for behavior al modification of salt intake reduction in patients w ith heart disease

The effects of Nutrition monitoring app for behavior al modification of salt intake reduction in patients w ith heart disease - Behave-Salt study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1050250138
Enrollment
100
Registered
2025-10-24
Start date
2025-11-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Outpatient cardiac rehabilitation participants Heart failure, Hypertension,Cardiac reheblitation

Interventions

Participants in outpatient cardiac rehabilitation were given a device (Vivoo) that measures estimated salt intake through urine testing, which was used three times a week for eight weeks.

Sponsors

Murata Makoto
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients aged 18 years or older at the time of consent 2) Patients with heart failure or Cardiovascular disease patients with hypertension, or those requiring salt restriction therapy 3) Patients currently participating in or planning toparticipate in an outpatient cardiac rehabilitation program 4) Patients who have provided written consent

Exclusion criteria

Exclusion criteria: 1) Patients with a systolic blood pressure of less than 100 mmHg at the time of eligibility confirmation. 2) Patients with dizziness at the time of eligibility confirmation. 3) Patients who have not performed a cardiopulmonary exercise test or a 6-minute walk test at the time of outpatient cardiac rehabilitation. 4) Patients who have difficulty using Vivoo. 5) Patients undergoing maintenance dialysis. 6) Pregnant women. 7) Patients with obvious dementia who have difficulty following instructions. 8) Patients who are already participating in or plan to participate in a clinical trial involving another intervention during the study period. 9) Patients who the principal investigator or co-investigator deems inappropriate for participation in this study for other reasons.

Design outcomes

Primary

MeasureTime frame
Change in estimated daily salt intake

Secondary

MeasureTime frame
1) Percent change in estimated daily salt intake 2) Percent change in motivation to reduce salt intake using a transtheoretical model (TTM) 3) Changes and percentage changes in motivation to reduce salt intake using a visual analog scale (VAS) 4) Changes and percentage changes in systolic and diastolic blood pressure 5) Changes and percentage changes in BNP 6) Changes and percentage changes in extracellular water ratio (ECFR) 7) Changes and percentage changes in peak oxygen uptake (Peak VO2) and peak work rate (Peak WR) 8) Changes and percentage changes in minute ventilation vs. carbon dioxide exhaustion slope (VE vs. VCO2 slope)

Contacts

Public ContactMakoto Murata

National Cerebral and Cardiovascular Center

murata.makoto@ncvc.go.jp+81-6-6170-1070

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026